Similarly, the effective rate among P16 + patients was 28.57%, lower than the 52.83% seen in P16- patients ( p = 0.0880), though this difference did not reach statistical significance.
← all excerpts
Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer.
1
—
—